Lapatinib-free-base

Lapatinib is a synthetic, orally-active quinazoline with potential antineoplastic activity. Lapatinib reversibly blocks phosphorylation of the epidermal growth factor receptor (EGFR), ErbB2, and the Erk-1 and-2 and AKT kinases; it also inhibits cyclin D protein levels in human tumor cell lines and xenografts. EGFR and ErbB2 have been implicated in the growth of various tumor types.
Supplier Alfa Cytology
Product # BC0404
Pricing 100.0 mg, 500.0 mg, 1.0 g, 2.0 g, 5.0 g, inquire
Feedback